What is palonosetron used for? Palonosetron is commonly used to prevent nausea and vomiting that can happen when using medicines for cancer (chemotherapy) and after surgery. Palonosetron may also be ...

• The fixed emetogenic combination of fosnetupitant and palonosetron is available as an injection for administering directly into the vein by a healthcare provider. • The vial should be reconstituted ...

Palonosetron 20 μg/kg is noninferior to ondansetron for the control of chemotherapy-induced vomiting and nausea during the acute phase of the first treatment cycle in paediatric patients with cancer, ...

Aim Efficacy of intermittent palonosetron dosing in patients undergoing multiple-day, high-dose chemotherapy (HDC) was investigated. Patients & methods Fifty-eight patients received palonosetron (0.25 ...

Discover comprehensive details about Palonosetron, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

The aim of this study was to determine the efficacy of palonosetron combined with dexamethasone in prevention of chemotherapy (CT)-induced nausea and vomiting (CINV) in patients receiving high-dose ...

January 8, 2009 — A single dose of palonosetron is effective in preventing chemotherapy-induced nausea and vomiting, and also showed some superiority over an older agent, granisetron, when both agents ...

Netupitant/palonosetron shows statistically significant benefits compared with palonosetron alone (both in combination with dexamethasone) in people receiving emetogenic chemotherapy, mainly in the ...

Should all antiemetic guidelines recommend adding a NK1 receptor antagonist (NK1RA) in patients (pts) receiving carboplatin (carbo)? Efficacy evaluation of NEPA, a fixed combination of the NK1RA, ...

Lugano, Switzerland – June 24, 2024 – Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong focus in supportive ...

A phase III randomized double-blind study of prophylactic topical dapsone 5% versus moisturizer for cetuximab-induced papulopustular (acneiform) rash. Background: Olanzapine is proved to be effective ...